Abstract:Background: IBS and IBD are chronic gastrointestinal (GI) conditions associated with abdominal pain and abnormal bowel habits.Although IBS and IBD share common symptoms, their pathogenesis differs.Whereas IBD symptoms often arise from inflammatory or structural abnormalities, these objective markers are not consistently identified in IBS.Because symptom pathogenesis differs between disorders, we aimed to test whether symptom severity also varies between IBS and IBD.Methods: We compared GI symptoms using items developed for the NIH Patient Reported Outcome Measurement Information System (PROMIS®) that assessed frequency, severity, interference, and bother to 3 groups: (1) IBS patients from clinic and community populations, (2) IBD clinic patients, and (3) a U.S. general population (GP) sample selected by a commercial research firm (Cint) to approximate characteristics in the 2010 census.We measured 8 GI symptom domains: gastroesophageal reflux (GERD), disrupted swallowing, nausea/vomiting (N/V), belly pain, diarrhea, constipation, gas/bloating, and fecal incontinence/soling (FI).We measured overall symptom severity by averaging responses to items and transforming linearly to a 0-100 possible range (higher=worse).We compared group differences using analysis of covariance controlling for demographics and GI symptom-specific anxiety (Visceral Sensitivity Index [VSI]).To adjust for multiple comparisons for different symptoms, a p ,0.01 was used.Results: Respondents included 231 with IBS (mean age=44.8yrs; 68%F; 56.3% Caucasian), 190 with IBD (mean age=41.3yrs; 46%F; 58.4% Caucasian) and 1117 from the GP (mean age 45.7; 57%F; 72.7% Caucasian).Mean age, race/ethnicity, and education significantly differed between groups (all p ,0.01).The Table shows differences in GI symptom severity scores between groups.The GP had greater severity of GERD, disrupted swallowing and N/V compared to the patient groups.GERD severity differed among all groups with greatest severity in GP, followed by IBS, and then IBD.GP reported more disrupted swallowing than IBS and greater N/V than IBD.IBS patients reported greater severity of belly pain vs. GP and greater severity of constipation and gas/ bloating vs. GP and IBD.IBD patients had more severe diarrhea than the GP but not IBS.Conclusions: While IBS and IBD are conditions associated with greater lower GI symptom severity compared to the GP, they report less severe upper GI symptoms.Between disease states, IBS patients report numerically worse symptom severity vs. IBD for 7 of 8 GI symptom domains -only diarrhea appeared more severe in IBD.Although IBD is marked by objective inflammatory and anatomic biomarkers, this does not necessarily yield worse symptom severity than IBS -a condition without reliable biomarkers; the converse is true in this study.* P values after controlling for demographics and VSI.Values shown in bold are statistically significant.

Assessing the Quality of Life in Patients with Functional Gastrointestinal Disorders and Diseases of Gastrointestinal Motility

IDDF2018-ABS-0223 an Eastern Chinese Multicenter Survey on Health-Related Quality of Life in Inflammatory Bowel Disease Patients and Disease-Related Perception of Caregivers

Development And Validation Of A Questionnaire To Assess The Quality Of Life In Patients With Inflammatory Bowel Disease In Mainland China

Psychological Factors May Affect the Quality of Life in Irritable Bowel Syndrome Patients More Than the Gut Itself? A Multicenter Cross‐sectional Study

Prevalence and Risk Factors for Functional Bowel Disorders in South China: a Population Based Study Using the Rome III Criteria.

Tu2066 Prevalence of Irritable Bowel Syndrome in China: Joint Effects of Psychiatric Morbidity with Life Event Stress and Lactose Intake

Irritable Bowel Syndrome Consulters in Zhejiang Province: the Symptoms Pattern, Predominant Bowel Habit Subgroups and Quality of Life.

Illness Perception of Patients with Functional Gastrointestinal Disorders

Quality of life scales for patients with gastroesophageal reflux disease: A literature review

Health related quality of life in patients with chronic gastritis and peptic ulcer and factors with impact: a longitudinal study

Analysis of the clinical features and life quality of 184 patients with reflux esophagitis

[An Epidemiological and Quality of Life Study of Irritable Bowel Syndrome in Zhejiang Province].

Assessing Health-Related Quality of Life in Patients with Inflammatory Bowel Disease in Zhejiang, China.

Mediating effect of gastrointestinal symptoms on dietary behavior and quality of life in Chinese adults with chronic gastritis—a cross-sectional study

Gastroesophageal Reflux Disease Questionnaire (gerdq) in Real‐world Practice: A National Multicenter Survey on 8065 Patients

Different Therapeutic Approaches on Quality of Life in Patients with Inflammatory Bowel Disease

The quality of life in patients with chronic peptic ulcer and its influence factors

Quality of life and its influence factors of patients with chronic gastritis and peptic ulcer: application of QLICD-GM

Symptoms, Psychological Distress, Social Support, and Quality of Life of Chinese Patients Newly Diagnosed with Gastrointestinal Cancer

Quality of life and influencing factors of functional dyspepsia in different subtypes

Characteristics and risk factors of Functional Dyspepsia fulfilling the Rome IV Criteria overlapping with Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, and Functional Constipation in South China